Next Article in Journal
Where Are the tpy Embraces in [Zn{4′-(EtO)2OPC6H4tpy}2][CF3SO3]2?
Previous Article in Journal
Information Capacity of Positron Emission Tomography Scanners
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Crystal Structure of Bovine Alpha-Chymotrypsin in Space Group P65

by
Andrew C. Marshall
1,
Benjamin G. Keiller
2,
Jordan L. Pederick
1,
Andrew D. Abell
3 and
John B. Bruning
1,*
1
Institute for Photonics and Advanced Sensing (IPAS), School of Biological Sciences, The University of Adelaide, Adelaide 5005, Australia
2
School of Agriculture, Food and Wine, Department of Plant Science, The University of Adelaide, Adelaide 5005, Australia
3
Institute for Photonics and Advanced Sensing (IPAS), Department of Chemistry, and the Centre for Nanoscale BioPhotonics, The University of Adelaide, Adelaide 5005, Australia
*
Author to whom correspondence should be addressed.
Crystals 2018, 8(12), 460; https://doi.org/10.3390/cryst8120460
Submission received: 21 November 2018 / Revised: 4 December 2018 / Accepted: 7 December 2018 / Published: 10 December 2018
(This article belongs to the Section Biomolecular Crystals)

Abstract

:
Chymotrypsin is a protease that is commonly used as a standard for protein crystallization and as a model system for studying serine proteases. Unliganded bovine α-chymotrypsin was crystallized at neutral pH using ammonium sulphate as the precipitant, resulting in crystals that conform to P65 symmetry with unit cell parameters that have not been reported previously. Inspection of crystallographic interfaces revealed that the major interface between any two molecules in the crystal lattice represents the interface of the biological dimer, as previously observed for crystals of unliganded α-chymotrypsin grown at low pH in space group P21.

1. Introduction

Chymotrypsin is a serine endopeptidase secreted from the pancreas, and it is involved in proteolytic digestion. Chymotrypsinogen A is activated via hydrolysis of the Arg15-Ile16 peptide bond by trypsin to produce π-chymotrypsin. Autolytic cleavage of π-chymotrypsin at peptide bonds 13-14, 146-147, and 148-149 then follows to produce α-chymotrypsin, which consists of three separate polypeptides cross-linked by five disulphide bonds [1]. Chymotrypsin was one of the first protein structures solved by X-ray crystallography, and was the first solved structure of a protease [2]. Researchers quickly discovered that chymotrypsin can easily be crystallized using ammonium sulphate as a precipitant, often with lower pH (<4.5), leading to crystal forms conforming to the space group P21, while at higher pH (>4.5), crystal forms usually conform to the space group P42212, with the latter crystal form primarily used for crystallization with a ligand. Since this discovery, a number of other crystal forms have been reported. A summary of representative published crystal forms is presented in Table S1. Given its long history of study and ease of purification, chymotrypsin has been used as a model system for several purposes. Chymotrypsin is often used in combination with other proteins as a control to study protein crystallization itself, such as probing general crystallization techniques as well as general seeding techniques. In addition, many other proteases, such as the proteasome, elastases, cathepsins, and calpain, have proven difficult to study in vitro due to problems in purification. As such, chymotrypsin is often used as a model for studying ligand-protease interactions, especially with regard to structure-guided drug design [3,4,5]. Here, we report a previously undocumented crystal form of α-chymotrypsin (Table 1) solved by X-ray crystallography to a resolution of 1.86 Å in the space group P65.

2. Materials and Methods

2.1. Macromolecule Production

TLCK (Tosyl-L-lysyl-chloromethane hydrochloride)-treated α-chymotrypsin A isolated from bovine pancreas was purchased from Worthington Biochemical Corporation (Lakewood, NJ, USA) as a dialyzed (1 mM HCl), lyophilized powder (product code: CDTLCK) and dissolved in 0.1 M HEPES pH 7.0 to a final concentration of 20 mg/ml.
Amino acids 14, 15, 147, and 148 (underlined) were removed during processing of chymotrypsinogen A to produce α-chymotrypsin.

2.2. Crystallization

Protein was crystallized by vapour-diffusion using the hanging drop method at 16 °C. Crystals formed as rods with a maximum dimension of approximately 400 µm after 1 month with 2 M ammonium sulphate as the reservoir solution. Complete details of the crystallization conditions are given in Table 2. Prior to data collection, crystals were cryoprotected in Paratone-N (Hampton Research) and flash cooled in liquid nitrogen.

2.3. Data Collection and Processing

X-ray diffraction data were collected at 13000 eV from a single crystal using the MX1 beamline [6] at the Australian Synchrotron. A total of 179 frames were collected at 1° intervals with 1° oscillation. Data were processed using iMosflm (CCP4i, Oxford, UK) [7]. Data collection and processing statistics are shown in Table 3.

2.4. Structure Solution and Refinement

The structure of α-chymotrypsin was solved by molecular replacement using Phaser-MR [9] with chain A of the 4Q2K (with all non-protein atoms removed) as the search model. The final solution contained four copies of the search model in the asymmetric unit, with a translation function Z (TFZ) score of 50.7, and log-likelihood gain (LLG) of 10450. Refinement of atomic coordinates was performed by successive iterations of refinement using phenix.refine [10] and manual rebuilding in Coot [11]. Torsion-angle non-crystallographic symmetry (NCS) restraints were applied. Anisotropic refinement of B-factors was restricted to torsion-liberation-screw (TLS) groups [12]. Both NCS and TLS groups were defined automatically using phenix.refine. Optimization of the relative X-ray/stereochemistry and X-ray/B-factor weights was performed in the final rounds of refinement. Refinement statistics are shown in Table 4. The structure factors and atomic coordinates for the final model were deposited at the Protein Data Bank (PDB) under accession 6DI8. Molecular graphic images were produced using PyMOL (v2.0.7, Schrodinger, LLC, New York City, NY, USA) [13].

3. Results and Discussion

The structure of bovine α-chymotrypsin was solved in space group P65 using data to 1.86 Å. The unit cell parameters (Table 3) have not been reported previously for crystals of α-chymotrypsin with this symmetry, indicating that this is a novel crystal form Residues 1 to 245 were confidently modelled into the electron density, with the exceptions of Ser14, Arg15, Thr147, and Asn148, which were removed during chymotrypsin activation and autolysis. The final model displays favourable geometric statistics; the only Ramachandran outlier present in each molecule is Ile99 (electron density for Ile99 shown in Figure 1), which forms part of the S2 site and its conformation is well supported by strong electron density. All five disulphide bonds are clearly observed in each subunit. The arrangement of subunits is such that the N-terminal peptide (residues 1-13) is at the centre of the asymmetric unit, with the active site facing out away from the centre. The asymmetric unit contains an arrangement of four subunits of α-chymotrypsin exhibiting two-fold non-crystallographic rotational symmetry through three mutually perpendicular axes (Figure 2).
Due to this being a new crystal form, the crystallographic interfaces for this P65 structure of unliganded α-chymotrypsin were analysed using PISA (Proteins, Interfaces, Structures and Assemblies) [14] (http://www.ebi.ac.uk/pdbe/prot_int/pistart.html) and compared to the structure of unliganded α-chymotrypsin solved in spacegroup P21 (PDB ID: 4CHA), which contains two chymotrypsin molecules in the asymmetric unit [15]. Table 5 details the interfaces for α-chymotrypsin solved in spacegroup P65. Interfaces for the P21 structure are listed in Table S2. Overall, 77% of interface residues for the P65 crystal form are at interfaces in the P21 structure. Interface 1 is largely conserved in each of the structures, involving 11 hydrogen bonds and 1 salt bridge, and is formed between molecules of the asymmetric unit of the P21 structure, but between symmetry-mates of our P65 crystal (Figure 3). This is the dimerization interface of α-chymotrypsin, which is formed by the active site face of each monomer [15,16]. Thus, the tetramer asymmetric unit observed in P65 contains four subunits; each individual subunit forms a biological assembly (dimer) with crystallographic symmetry mates. Interface 2 also consists of the same residues for the P65 and P21 forms. Multiple bonding interactions are observed at this interface for the P65 crystal form, with 10 hydrogen bonds and 2 salt bridges identified. For the P21 crystal form, however, only a single salt bridge is present. This is consistent with tighter packing at the central interfaces of the P65 crystal form. Although most of the residues involved in interface formation are shared between these structures, interfaces 3–6 were not conserved, due to the evident difference in crystal packing. The residues forming each of these interfaces in space group P65 were shared across several interfaces of the P21 crystal form.
It has been reported previously that changes in pH can affect the crystal form of α-chymotrypsin [17,18]. It is possible that the observed differences in crystal packing are due to the higher pH for the P65 crystal form, being crystallized at pH 7.0, compared to pH 4.2 for the P21 crystal form.

Supplementary Materials

The following are available online at https://www.mdpi.com/2073-4352/8/12/460/s1, Table S1: Summary of space groups and unit cell parameters for representative bovine α-chymotrypsin crystal structures currently deposited at the PDB, Table S2: Crystallographic interfaces with areas greater than 100 Å2 for unliganded bovine α-chymotrypsin in space group P21 (PDB: 4CHA).

Author Contributions

Conceptualization, J.B. and A.A.; methodology, B.K.; software, A.M.; validation, A.M., J.P., and J.B.; formal analysis, J.P and A.M.; investigation, B.K. and A.M.; resources, J.B and A.M.; data curation, A.M.; writing—original draft preparation, A.M., J.P., and J.B.; writing—review and editing, A.M., J.P., and J.B.; visualization, A.M., J.P., and J.B.; supervision, J.B. and A.A.; project administration, J.B and A.A.; funding acquisition, A.A.

Funding

This research was funded by the Australian Research Council (CE140100003).

Acknowledgments

This research was undertaken on the MX1 beamline at the Australian Synchrotron, part of ANSTO.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Sharma, S.K.; Hopkins, T.R. Activation of bovine chymotrypsinogen-A - isolation and characterization of mu-chymotrypsin and omega-chymotrypsin. Biochemistry 1979, 18, 1008–1013. [Google Scholar] [CrossRef] [PubMed]
  2. Matthews, B.W.; Sigler, P.B.; Henderson, R.; Blow, D.M. 3-dimensional structure of tosyl-alpha-chymotrypsin. Nature 1967, 214, 652–656. [Google Scholar] [CrossRef] [PubMed]
  3. Chua, K.C.; Pietsch, M.; Zhang, X.; Hautmann, S.; Chan, H.Y.; Bruning, J.B.; Gutschow, M.; Abell, A.D. Macrocyclic protease inhibitors with reduced peptide character. Angew. Chem. Int. Ed. Engl. 2014, 53, 7828–7831. [Google Scholar] [CrossRef] [PubMed]
  4. Roussel, A.; Mathieu, M.; Dobbs, A.; Luu, B.; Cambillau, C.; Kellenberger, C. Complexation of two proteic insect inhibitors to the active site of chymotrypsin suggests decoupled roles for binding and selectivity. J. Biol. Chem. 2001, 276, 38893–38898. [Google Scholar] [CrossRef] [PubMed]
  5. Neidhart, D.; Wei, Y.; Cassidy, C.; Lin, J.; Cleland, W.W.; Frey, P.A. Correlation of low-barrier hydrogen bonding and oxyanion binding in transition state analogue complexes of chymotrypsin. Biochemistry 2001, 40, 2439–2447. [Google Scholar] [CrossRef] [PubMed]
  6. McPhillips, T.M.; McPhillips, S.E.; Chiu, H.J.; Cohen, A.E.; Deacon, A.M.; Ellis, P.J.; Garman, E.; Gonzalez, A.; Sauter, N.K.; Phizackerley, R.P.; et al. Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines. J. Synchrotron Radiat. 2002, 9, 401–406. [Google Scholar] [CrossRef] [PubMed]
  7. Leslie, A.G.W.; Powell, H.R. Processing Diffraction Data with Mosflm. In Evolving Methods for Macromolecular Crystallography; Read, R.J., Sussman, J.L., Eds.; Springer: Dordrecht, The Netherlands, 2007; Volume 245, pp. 41–51. [Google Scholar]
  8. Karplus, P.A.; Diederichs, K. Assessing and maximizing data quality in macromolecular crystallography. Curr. Opin. Struct. Biol. 2015, 34, 60–68. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. McCoy, A.J.; Grosse-Kunstleve, R.W.; Adams, P.D.; Winn, M.D.; Storoni, L.C.; Read, R.J. Phaser crystallographic software. J. Appl. Crystallogr. 2007, 40, 658–674. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Afonine, P.V.; Grosse-Kunstleve, R.W.; Echols, N.; Headd, J.J.; Moriarty, N.W.; Mustyakimov, M.; Terwilliger, T.C.; Urzhumtsev, A.; Zwart, P.H.; Adams, P.D. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D Biol. Crystallogr. 2012, 68, 352–367. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Emsley, P.; Lohkamp, B.; Scott, W.G.; Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 2010, 66, 486–501. [Google Scholar] [CrossRef] [PubMed]
  12. Winn, M.D.; Isupov, M.N.; Murshudov, G.N. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr. D Biol. Crystallogr. 2001, 57, 122–133. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Schrodinger, LLC. The PyMOL Molecular Graphics System, Version 1.8. 2015. [Google Scholar]
  14. Krissinel, E.; Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 2007, 372, 774–797. [Google Scholar] [CrossRef] [PubMed]
  15. Tsukada, H.; Blow, D.M. Structure of alpha-chymotrypsin refined at 1.68 A resolution. J. Mol. Biol. 1985, 184, 703–711. [Google Scholar] [CrossRef]
  16. Ikeda, K.; Kunugi, S.; Ise, N. pH dependence of the formation of dimeric alpha-chymotrypsin and its catalytic activity. J. Biochem. 1982, 92, 541–546. [Google Scholar] [CrossRef] [PubMed]
  17. Corey, R.B.; Battfay, O.; Brueckner, D.A.; Mar, F.G. Preliminary X-ray diffraction studies of crystal forms of free and inhibited chymotrypsin. Biochim. Biophys. Acta 1965, 94, 535–545. [Google Scholar] [CrossRef]
  18. Vandlen, R.L.; Tulinsky, A. Changes in the tertiary structure of alpha-chymotrypsin with change in pH: p4 4.2–6.7. Biochemistry 1973, 12, 4193–4200. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Reduced model bias map of residue Ile99 in the chymotrypsin structure solved in space group P65. A composite omit map (2Fo-Fc, contoured at 1.5 σ) is displayed as blue mesh and proteins are shown as yellow sticks.
Figure 1. Reduced model bias map of residue Ile99 in the chymotrypsin structure solved in space group P65. A composite omit map (2Fo-Fc, contoured at 1.5 σ) is displayed as blue mesh and proteins are shown as yellow sticks.
Crystals 08 00460 g001
Figure 2. Asymmetric unit of bovine α-chymotrypsin crystallized in space group P65 (PDB ID: 6DI8). The four chymotrypsin molecules are coloured differently and shown in cartoon representation. The view is down one axis of two-fold non-crystallographic symmetry; the other two perpendicular axes are shown as black bars. The nucleophilic serines (Ser195) at the catalytic site are shown as sticks. N- and C-termini are labelled.
Figure 2. Asymmetric unit of bovine α-chymotrypsin crystallized in space group P65 (PDB ID: 6DI8). The four chymotrypsin molecules are coloured differently and shown in cartoon representation. The view is down one axis of two-fold non-crystallographic symmetry; the other two perpendicular axes are shown as black bars. The nucleophilic serines (Ser195) at the catalytic site are shown as sticks. N- and C-termini are labelled.
Crystals 08 00460 g002
Figure 3. The major interface (“interface 1”—see text) present in the crystal lattice is conserved between α-chymotrypsin crystallized in space group P65 and in P21. (A) A single chymotrypsin molecule of the asymmetric unit of the P65 crystal form is shown in cartoon representation coloured green; the symmetry mate is coloured grey. Interfacing residues are shown as sticks; catalytic residues (His57, Asp102 and Ser195) are coloured red. (B) The asymmetric unit of α-chymotrypsin crystallized in P21 (PDB ID: 4CHA).
Figure 3. The major interface (“interface 1”—see text) present in the crystal lattice is conserved between α-chymotrypsin crystallized in space group P65 and in P21. (A) A single chymotrypsin molecule of the asymmetric unit of the P65 crystal form is shown in cartoon representation coloured green; the symmetry mate is coloured grey. Interfacing residues are shown as sticks; catalytic residues (His57, Asp102 and Ser195) are coloured red. (B) The asymmetric unit of α-chymotrypsin crystallized in P21 (PDB ID: 4CHA).
Crystals 08 00460 g003
Table 1. Macromolecule information.
Table 1. Macromolecule information.
Source OrganismBos taurus
Complete amino acid sequence of chymotrypsinogen A (UniProt: P00766)CGVPAIQPVL SGLSRIVNGE EAVPGSWPWQ VSLQDKTGFH FCGGSLINEN WVVTAAHCGV TTSDVVVAGE FDQGSSSEKI QKLKIAKVFK NSKYNSLTIN NDITLLKLST AASFSQTVSA VCLPSASDDF AAGTTCVTTG WGLTRYTNAN TPDRLQQASL PLLSNTNCKK YWGTKIKDAM ICAGASGVSS CMGDSGGPLV CKKNGAWTLV GIVSWGSSTC STSTPGVYAR VTALVNWVQQ TLAAN
Table 2. Crystallization.
Table 2. Crystallization.
MethodVapour Diffusion, Hanging Drop
Plate type24-well tissue culture plate with glass cover slips sealed using vacuum grease
Temperature (K)289
Protein concentration20 mg/mL
Buffer composition of protein solution0.1 M HEPES pH 7.0
Composition of reservoir solution2 M (NH4)2SO4
Volume and ratio of drop2 µL drop volume with 1:1 ratio of protein solution to reservoir solution
Volume of reservoir0.5 mL
Table 3. Data collection and processing. Values for the outer shell are given in parentheses. All data were collected from a single crystal.
Table 3. Data collection and processing. Values for the outer shell are given in parentheses. All data were collected from a single crystal.
Diffraction SourceAustralian Synchrotron Beamline MX1
Wavelength (Å)0.9537
Temperature (K)100
DetectorADSC quantum 210r CCD
Crystal-detector distance (mm)184.95
Rotation range per image (°)1
Total rotation range (°)179
Exposure time per image (s)1
Space groupP65
a, b, c (Å)126.8, 126.8, 122.0
α, β, γ (°)90, 90, 120
Mosaicity (°)0.53
Resolution range (Å)29.55–1.86 (1.89–1.86)
Total No. of reflections868057 (31308)
No. of unique reflections93385 (4606)
Completeness (%)100.0 (99.7)
Redundancy9.3 (6.8)
I/σ(I)〉12.2 (1.0 )
CC1/20.998 (0.383)
Rmerge0.119 (1.924)
Rp.i.m.0.041 (0.779)
Overall B factor from Wilson plot (Å2)25.83
Mean I/σ(I) falls below 2.0 at a resolution of 1.97 å. CC1/2 was used to inform resolution cut-off [8].
Table 4. Structure solution and refinement. Values for the outer shell are given in parentheses.
Table 4. Structure solution and refinement. Values for the outer shell are given in parentheses.
Resolution range (Å)28.132–1.859 (1.925–1.859)
Completeness (%)99.81 (99.63)
σ cutoffF > 0.0 σ(F)
No. of reflections, working set93185 (8787)
No. of reflections, test set4889 (468)
Final Rwork0.1885 (0.3317)
Final Rfree0.2252 (0.3416)
Cruickshank DPI (Å)0.219
No. of non-H atoms
Protein7201
Sulphate ion65
Solvent1100
Total8366
R.M.S. deviations
Bonds (Å)0.0059
Angles (°)0.78
Average B factors (Å2)
Protein33.1
Sulphate ion80.2
Water43.6
Ramachandran plot
Most favoured (%)97.45
Allowed (%)2.13
Table 5. Crystallographic interfaces for unliganded α-chymotrypsin in space group P65.
Table 5. Crystallographic interfaces for unliganded α-chymotrypsin in space group P65.
Interface #Symmetry OperationInterface Area (Å2)Subunits
1X-Y, X+1, Z-1/61049B, C
X-Y, X, Z-1/61038A, D
2X, Y, Z668D, B
X, Y, Z625C, A
3X, Y, Z562D, A
X, Y, Z539C, B
4X, Y, Z344B, A
X, Y, Z340D, C
5-X-1, -Y, Z-1/2361A, C
-X-1, -Y, Z-1/2218B, D
6-X-1, -Y, Z-1/2145A, D
-X-1, -Y, Z-1/2136B, C
Subunits A–D constitute the asymmetric unit. Each subunit is composed of three separate polypeptide chains, crosslinked by disulphide bonds.

Share and Cite

MDPI and ACS Style

Marshall, A.C.; Keiller, B.G.; Pederick, J.L.; Abell, A.D.; Bruning, J.B. Crystal Structure of Bovine Alpha-Chymotrypsin in Space Group P65. Crystals 2018, 8, 460. https://doi.org/10.3390/cryst8120460

AMA Style

Marshall AC, Keiller BG, Pederick JL, Abell AD, Bruning JB. Crystal Structure of Bovine Alpha-Chymotrypsin in Space Group P65. Crystals. 2018; 8(12):460. https://doi.org/10.3390/cryst8120460

Chicago/Turabian Style

Marshall, Andrew C., Benjamin G. Keiller, Jordan L. Pederick, Andrew D. Abell, and John B. Bruning. 2018. "Crystal Structure of Bovine Alpha-Chymotrypsin in Space Group P65" Crystals 8, no. 12: 460. https://doi.org/10.3390/cryst8120460

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop